As part of the firm’s “US Conviction List – Directors’ Cut” for March. Goldman Sachs analyst removed Apple (AAPL), Merck (MRK), and Vertex Pharmaceuticals (VRTX) from its Conviction Buy List.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AAPL:
- Here Are the Top 5 Stocks by Market Cap – March 2024
- Apple Stock (NASDAQ:AAPL): Will the Vision Pro Reignite Its Growth?
- Apple Stock Can Reach $250 Without EV Car, Says Daniel Ives
- Apple (NASDAQ:AAPL) Steps Up Self-Service Repairs, Shares Slip
- Apple sunk $10B in its now canceled car project, NY Times says